ʻO Palmitoylethanolamide (PEA Micro) mea hana pauka CAS No.: 544-31-0 99% maemae min. no nā mea hoʻohui
Nā Kūlana Huahana
inoa huahana | PEA micro |
inoa ʻē aʻe | N-(2-HYDROXYETHYL)HEXADECANAMIDE; N-HEXADECANOYLETHANOLAMINE; PEAPALMIDROL; PALMITYLETHANOLAMIDE; PALMITOYLETHChemicalbookANOLAMIDE |
CAS No. | 544-31-0 |
ʻAno molekala | C18H37NO2 |
Kaumaha molekula | 299.49 |
Maemae | 99.0% |
Ka nana aku | ʻO ka pauka kristal keʻokeʻo |
Hoʻopili | 25Kg/ pahu |
Palapala noi | Nā mea maka o nā huahana mālama ola |
Hoʻolauna huahana
ʻO ka Palmitoylethanolamide kahi mole messenger lipid i ʻike mua ʻia i ka hopena o 1950s. Aia ia i ka papa o nā pūhui i kapa ʻia he endocannabinoids, he mau mea kūlohelohe ia e launa pū me ka ʻōnaehana endocannabinoid o ke kino. ʻAʻole like me nā cannabinoids ʻē aʻe e like me THC i loaʻa i ka lāʻau cannabis, PEA ʻaʻole psychoactive a ʻaʻole hoʻopuka i nā hopena hoʻololi noʻonoʻo. ʻO ka ʻōnaehana endocannabinoid (ECS) kahi pūnaewele paʻakikī o nā mea loaʻa a me nā endocannabinoid i loaʻa ma ke kino holoʻokoʻa. He kuleana koʻikoʻi ia i ka hoʻoponopono ʻana i nā ʻano hana physiological, me ka ʻike ʻana i ka ʻeha, ka mumū, a me ke ʻano. Hoʻohana ʻo PEA ma ke ʻano he ligand endogenous no kahi loaʻa kikoʻī i loko o ka ECS i kapa ʻia he peroxisome proliferator-activated receptor-α (PPAR-α). Ma ka hoʻoulu ʻana i kēia mea loaʻa, hoʻohana ka PEA i kāna mau hopena anti-inflammatory a me analgesic. Hōʻike nā haʻawina e hiki i ka Palmitoylethanolamide ke kōkua i ka mālama ʻana i ka ʻeha mau, me ka neuropathic a me ka ʻeha ʻeha. Hana ia ma ka ho'ēmiʻana i ka hoʻokuʻuʻana o nā mea pro-inflammatory a me ka hoʻoponoponoʻana i ka hoʻouluʻana o nā pūnaewele immune i komo i ka pane inflammatory. Ua hōʻike ka nui o nā hoʻokolohua lapaʻau i ka maikaʻi o ka PEA i ka hōʻemi ʻana i ka nui o ka ʻeha a me ka hoʻomaikaʻi ʻana i ka maikaʻi o ke ola i nā maʻi me nā ʻano maʻi ʻeha mau.
Hiʻona
(1) Maʻemaʻe kiʻekiʻe: Hiki i ka PEA ke loaʻa nā huahana maʻemaʻe kiʻekiʻe ma o ka hoʻomaʻemaʻe ʻana i nā kaʻina hana. ʻO ka maʻemaʻe kiʻekiʻe, ʻoi aku ka maikaʻi o ka bioavailability a me ka liʻiliʻi o nā hopena ʻino.
(2) Palekana: Palekana kiʻekiʻe, liʻiliʻi nā hopena ʻino.
(3) Paʻa: He kūpaʻa maikaʻi ka PEA a hiki ke mālama i kāna hana a me ka hopena ma lalo o nā kaiapuni like ʻole a me nā kūlana mālama.
Nā noi
Hoʻohana ʻia ma ke ʻano he meaʻai meaʻai, ʻo Palmitoylethanolamide kahi amide momona momona e hoʻohana ana i nā hopena anti-inflammatory, analgesic, a me neuroprotective ma o ka modulation o ka ʻōnaehana endocannabinoid. ʻO kāna mau pono kūpono no ka mālama ʻana i ka ʻeha mau loa a me nā kūlana olakino ʻē aʻe he koho hoihoi ia no nā poʻe e ʻimi nei i nā mea kūlohelohe. Eia kekahi, ʻo ka PEA kekahi mea hoʻohui kūlohelohe kūlohelohe a me ka intermediate pharmaceutical, hiki ke hoʻohana ʻia i ka noiʻi noiʻi a me nā kaʻina hana hoʻomohala a me ka noiʻi lāʻau kemika a me nā kaʻina hana hoʻomohala.